Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake ... which could lead to better and more personalized treatment." Benjamin Horne, PhD, director ...

An international, multidisciplinary team of leading neuro-oncology researchers and clinicians has released new ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

Background: Previous studies have demonstrated the plasticity of perceptual sensitivity and compensatory mechanisms of ...

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...

Ponce said that after a comprehensive assessment, they prepare a treatment plan for the patient and bring their ...

The Food and Drug Administration (FDA) has granted accelerated approval to Kebilidi™ (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-amino acid ...

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

About SciBase SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care ...